Eulambius M. Mlugu

Dar Es Salaam, United Republic of Tanzania

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Correction: The MARC SE-Africa dashboard: Joining forces to counteract emerging antimalarial resistance in South and East Africa.

Correction: The MARC SE-Africa dashboard: Joining forces to counteract emerging antimalarial resistance in South and East Africa.

Journal: PLOS digital health

Published: July 20, 2026

Post-market surveillance of antiretroviral drug quality in Tanzania in the context of rising HIV drug resistance.

Post-market surveillance of antiretroviral drug quality in Tanzania in the context of rising HIV drug resistance.

Journal: Scientific reports

Published: October 08, 2025

Training Needs Assessment and Capacity Building of Clinical Trial Assessors and Ethical Reviewers to Strengthen Regulatory Review in Tanzania.

Training Needs Assessment and Capacity Building of Clinical Trial Assessors and Ethical Reviewers to Strengthen Regulatory Review in Tanzania.

Journal: Therapeutic innovation & regulatory science

Published: July 14, 2025

Dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a systematic review and individual participant data meta-analysis.

Dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a systematic review and individual participant data meta-analysis.

Journal: EClinicalMedicine

Published: February 22, 2025

The MARC SE-Africa dashboard: Joining forces to counteract emerging antimalarial resistance in South and East Africa.

The MARC SE-Africa dashboard: Joining forces to counteract emerging antimalarial resistance in South and East Africa.

Journal: PLOS digital health

Published: January 08, 2025

Dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a systematic review and individual participant data meta-analysis.

Dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a systematic review and individual participant data meta-analysis.

Journal: medRxiv : the preprint server for health sciences

Published: December 09, 2024

Resistant malaria parasites gaining momentum in Africa.

Resistant malaria parasites gaining momentum in Africa.

Journal: The Lancet. Infectious diseases

Published: June 16, 2024

A Comprehensive Assessment of Quality of Antimalarial Medicines in Mainland Tanzania: Insights from Five Years of Postmarket Surveillance.

A Comprehensive Assessment of Quality of Antimalarial Medicines in Mainland Tanzania: Insights from Five Years of Postmarket Surveillance.

Journal: The American journal of tropical medicine and hygiene

Published: March 04, 2024

Efficacy of ivermectin and albendazole combination in suppressing transmission of lymphatic filariasis following mass administration in Tanzania: a prospective cohort study.

Efficacy of ivermectin and albendazole combination in suppressing transmission of lymphatic filariasis following mass administration in Tanzania: a prospective cohort study.

Journal: Infectious diseases of poverty

Published: February 21, 2024

Evaluation of Dose Adjustment in Patients With Renal Impairment at Muhimbili National Hospital in Tanzania.

Evaluation of Dose Adjustment in Patients With Renal Impairment at Muhimbili National Hospital in Tanzania.

Journal: Hospital pharmacy

Published: January 15, 2024

Pharmacokinetics of piperaquine and its association with intermittent malaria preventive therapy outcomes during pregnancy.

Pharmacokinetics of piperaquine and its association with intermittent malaria preventive therapy outcomes during pregnancy.

Journal: BMC pharmacology & toxicology

Published: July 13, 2023

Incidence and determinants of adverse events in individuals with HIV commencing Dolutegravir-based antiretroviral therapy in mainland Tanzania.

Incidence and determinants of adverse events in individuals with HIV commencing Dolutegravir-based antiretroviral therapy in mainland Tanzania.

Journal: Scientific reports

Published: May 25, 2023

Showing 1-12 of 21

Last Updated: 09/26/2026